Further validation of the Toronto extremity salvage score for lower extremity soft tissue sarcoma based on Finnish patients.
暂无分享,去创建一个
[1] Sakae Tanaka,et al. Minimal clinically important differences in Toronto Extremity Salvage Score for patients with lower extremity sarcoma. , 2020, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[2] C. Blomqvist,et al. Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review , 2019, Annals of Surgical Oncology.
[3] C. Blomqvist,et al. Functional Outcome After Lower Extremity Soft Tissue Sarcoma Treatment: A Pilot Study Based on Translated and Culturally Adapted Measures , 2018, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.
[4] L M Bouter,et al. COSMIN guideline for systematic reviews of patient-reported outcome measures , 2018, Quality of Life Research.
[5] H. Vet,et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures , 2017, Quality of Life Research.
[6] T. V. Vliet Vlieland,et al. Cross-Cultural Adaptation, Translation, and Validation of the Toronto Extremity Salvage Score for Extremity Bone and Soft Tissue Tumor Patients in Netherlands , 2017, Sarcoma.
[7] T. Higashi,et al. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan. , 2017, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[8] L. Rochester,et al. Objective clinical measurement of physical functioning after treatment for lower extremity sarcoma - A systematic review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] Zezhang Zhu,et al. Cross-cultural adaptation and validation of the Chinese version of Toronto Extremity Salvage Score for patients with extremity sarcoma , 2016, SpringerPlus.
[10] A. Davis,et al. Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the lower extremities , 2015, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[11] Han-Soo Kim,et al. Cross‐cultural adaptation and validation of the Korean Toronto Extremity Salvage Score for extremity sarcoma , 2015, Journal of surgical oncology.
[12] P. Choong,et al. A Systematic Review of the Recent Quality of Life Studies in Adult Extremity Sarcoma Survivors , 2012, Sarcoma.
[13] C. Terwee,et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. , 2010, Journal of clinical epidemiology.
[14] A. Davis,et al. Cultural adaptation, translation and validation of a functional outcome questionnaire (TESS) to Portuguese with application to patients with lower extremity osteosarcoma , 2008, Pediatric blood & cancer.
[15] Ron D Hays,et al. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] S. Devesa,et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases , 2006, International journal of cancer.
[17] Ross D Crosby,et al. Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.
[18] H. Sintonen. The 15D instrument of health-related quality of life: properties and applications , 2001, Annals of medicine.
[19] A. Davis. Functional outcome in extremity soft tissue sarcoma. , 1999, Seminars in radiation oncology.
[20] B. Everitt. The Cambridge Dictionary of Statistics , 1998 .
[21] C. Bombardier,et al. Development of a measure of physical function for patients with bone and soft tissue sarcoma , 1996, Quality of Life Research.
[22] C. McHorney,et al. Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.
[23] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[24] D. Streiner,et al. Health Measurement Scales: A practical guide to thier development and use , 1989 .
[25] L. Cronbach. Coefficient alpha and the internal structure of tests , 1951 .
[26] T. Higashi,et al. Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan. , 2017, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[27] A. Safwat,et al. Validation of a Danish version of the Toronto Extremity Salvage Score questionnaire for patients with sarcoma in the extremities. , 2014, Danish medical journal.
[28] M. Mukaka,et al. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. , 2012, Malawi medical journal : the journal of Medical Association of Malawi.
[29] C. Terwee,et al. Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.
[30] Holger J. Schünemann,et al. Health and Quality of Life Outcomes , 2006 .
[31] R. Peterson. A Meta-Analysis of Variance Accounted for and Factor Loadings in Exploratory Factor Analysis , 2000 .
[32] E M Badley,et al. Evaluating functional outcome in patients with lower extremity sarcoma. , 1999, Clinical orthopaedics and related research.
[33] W. Enneking,et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. , 1993, Clinical orthopaedics and related research.